FilingSEC EDGAR8-K
Cardiff Oncology Settles Litigation And Amends License Agreement With Nerviano
· SEC accepted
StageSettlement and Amendment
Filing content
Cardiff Oncology settled its patent litigation with Nerviano without monetary payment and amended the license agreement for onvansertib to support ongoing clinical development.
AI summary of the filing. Please also check the source.Related companies
Analyzed by WAPE AI.
Preparing English content…
Comments —
Loading comments…